Immunotherapy vs Targeted Therapy

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library

Dr Morganna Freeman explains the difference between immunotherapies and targeted therapies in plain language for patients to easily understand.

September 2, 2015

Challenges with Oral Oncolytics for Payers and Practice Managers

Dixie-Lee Esseltine, MD and George Mulligan, PhD shed light on the challenges that payers and practice managers will face as more oncolytics come into the market.

August 15, 2013

The Evolving Role of Genotypic Data

Dr. Mesa recognizes that although genotypic data is not yet being used to select treatment choice or dosing in myelofibrosis, it is used to address the issues of prognosis and burden of disease.